AlphaCrest Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

AlphaCrest Capital Management’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-36,746	Closed	-$482K	–	942
2022 Q3	$482K	Sell	36,746 -94,827	-72%	-$1.4M	0.03%	990
2022 Q2	$1.84M	Buy	131,573 +108,467	+469%	+$1.45M	0.09%	365
2022 Q1	$344K	Sell	23,106 -169,238	-88%	-$2.32M	0.02%	1060
2021 Q4	$2.6M	Buy	192,344 +150,512	+360%	+$2.13M	0.1%	296
2021 Q3	$616K	Buy	41,832 +30,797	+279%	+$520K	0.03%	830
2021 Q2	$201K	Sell	11,035 -10,860	-50%	-$193K	0.01%	1196
2021 Q1	$380K	Buy	+21,895	New	+$385K	0.02%	925
2020 Q4	–	Sell	-10,947	Closed	-$151K	–	1253
2020 Q3	$151K	Buy	+10,947	New	+$161K	0.02%	1059
2019 Q4	–	Sell	-9,600	Closed	-$220K	–	1357
2019 Q3	$220K	Buy	+9,600	New	+$205K	0.01%	1189
2019 Q1	–	Sell	-38,900	Closed	-$641K	–	945
2018 Q4	$641K	Buy	+38,900	New	+$783K	0.19%	163

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AlphaCrest Capital Management's SBRA Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2022, closing a stake of 36,746 shares — an estimated $482K sold.

AlphaCrest Capital Management first reported a position in SBRA in Q4 2018 and held it in 10 quarters. The position peaked at $2.6M in Q4 2021. 327 funds tracked by Wall St. Rank hold SBRA as of Q4 2022.

AlphaCrest Capital Management reported no remaining Sabra Healthcare REIT position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 36,746 Sabra Healthcare REIT shares in Q4 2022, an estimated $482K.
AlphaCrest Capital Management first reported a position in Sabra Healthcare REIT in Q4 2018 and held it in 10 quarters.
AlphaCrest Capital Management's Sabra Healthcare REIT position peaked at $2.6M in Q4 2021.
327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.